We are live on ! Find out more
AVAI

Atlas Venture Associates IX Portfolio holdings

AUM $11.8M
1-Year Est. Return 58.35%
This Fund
S&P 500
This Quarter Est. Return
-23.24%
1 Year Est. Return
-58.35%
3 Year Est. Return
-89.8%
5 Year Est. Return
-87.69%
10 Year Est. Return
AUM
$229M
AUM Growth
-$71.8M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Communication Services 77.48%
2 Healthcare 22.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIRY
1
Firy Inc
FIRY
$156M
$170M 74.4%
1,145,493
SPRO icon
2
Spero Therapeutics
SPRO
$73.5M
$22M 9.62%
1,376,968
SURF
3
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$14.1M 6.15%
2,945,453
COGT icon
4
Cogent Biosciences
COGT
$7.14B
$7.87M 3.43%
916,832
SNAP icon
5
Snap
SNAP
$8.83B
$7.06M 3.08%
150,160
SYBX
6
DELISTED
Synlogic
SYBX
$6.42M 2.8%
176,798
NTLA icon
7
Intellia Therapeutics
NTLA
$1.57B
$1.18M 0.52%
10,000

Similar funds

Atlas Venture Associates IX's Q4 2021 Portfolio in Review

As of Q4 2021, Atlas Venture Associates IX held 7 positions worth $229M, down 24% from $301M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 0%. Atlas Venture Associates IX opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Communication Services at 77% of assets, down from 78% a quarter earlier, followed by Healthcare.

  • Atlas Venture Associates IX's ten largest holdings make up 100% of its $229M portfolio in Q4 2021.
  • Atlas Venture Associates IX opened 0 new positions and closed 0 in Q4 2021.
  • Atlas Venture Associates IX's portfolio value fell 24% quarter-over-quarter to $229M.

Based on Atlas Venture Associates IX's 13F filing for Q4 2021, filed 27 Jan 2022.